Cargando…

New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review

The novel coronavirus outbreak of SARS-CoV-2 first began in Wuhan, China, in December 2019. The most striking manifestation of SARS-CoV-2 is atypical pneumonia and respiratory complications; however, various neurological manifestations are now well recognized. Currently, there have been very few cas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sriwastava, Shitiz, Tandon, Medha, Kataria, Saurabh, Daimee, Maha, Sultan, Shumaila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Short Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549728/ https://www.ncbi.nlm.nih.gov/pubmed/33047223 http://dx.doi.org/10.1007/s00415-020-10263-1

Ejemplares similares

A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies
por: Kataria, Saurabh, et al.
Publicado: (2020)

Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series
por: Sriwastava, Shitiz, et al.
Publicado: (2021)

A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19
por: Tandon, Medha, et al.
Publicado: (2021)

Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature
por: Moreno-Escobar, Maria Camila, et al.
Publicado: (2021)

New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review
por: Tereshko, Yan, et al.
Publicado: (2022)

Commentary: Ocular myasthenia gravis: Interpreting the investigations
por: Nair, Akshay Gopinathan
Publicado: (2022)

COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2
por: Sriwastava, Shitiz, et al.
Publicado: (2021)

Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
por: Podury, Sanjiti, et al.
Publicado: (2021)

West Nile virus encephalitis: A report of two cases and review of neuroradiological features
por: Bailey, Christopher, et al.
Publicado: (2020)

Breast Carcinoma After Ocrelizumab Therapy in Multiple Sclerosis Patients: A Case Series and Literature Review
por: Kelsey, Andrew, et al.
Publicado: (2021)

Autoantibodies in Japanese patients with ocular myasthenia gravis
por: Nagaishi, Akiko, et al.
Publicado: (2020)

Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature
por: Khan, Erum, et al.
Publicado: (2021)

Clinical Features and Prognosis of Ocular Myasthenia Gravis Patients with Different Phenotypes
por: Wang, Li-Li, et al.
Publicado: (2015)

Controversies in Ocular Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2020)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Ocular myasthenia gravis: A review
por: Nair, Akshay Gopinathan, et al.
Publicado: (2014)

Update on ocular myasthenia gravis in Taiwan
por: Lin, Chao-Wen, et al.
Publicado: (2018)

Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)

New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine
por: Abicic, Ana, et al.
Publicado: (2022)

New-onset ocular myasthenia gravis following SARS-CoV-2 infection
por: Banerjee, Prabrisha, et al.
Publicado: (2022)

A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
por: Prasad, Apoorv, et al.
Publicado: (2021)

Myasthenia gravis: MuSK MG, late-onset MG and ocular MG
por: Deymeer, Feza
Publicado: (2020)

Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis
por: Bi, Zhuajin, et al.
Publicado: (2022)

Myasthenia Gravis: Do the Subtypes Matter?
por: Murthy, J. M. K.
Publicado: (2020)

Frontalis sling procedure for ocular myasthenia gravis
por: Asamura, Shinichi, et al.
Publicado: (2012)

Ocular myasthenia gravis in a setting of thyrotoxicosis
por: Chhabra, Sarabjeet, et al.
Publicado: (2013)

Sotalol‐induced generalized and ocular myasthenia gravis
por: Sharifkazemi, Mohammadbagher, et al.
Publicado: (2019)

Ocular Myasthenia Gravis: A Current Overview
por: Behbehani, Raed
Publicado: (2023)

Ophthalmologic clinical features of ocular myasthenia gravis
por: Kim, Do-Hyung, et al.
Publicado: (2023)

Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis
por: Kim, Ki Hoon, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of COVID-19 in West Virginia
por: Wen, Sijin, et al.
Publicado: (2021)

New‐onset myasthenia gravis after novel coronavirus 2019 infection
por: Taheri, Amirmasoud, et al.
Publicado: (2022)

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study
por: McPherson, Tarrant, et al.
Publicado: (2020)

A Critical Examination for the Pricing of Eculizumab and Efgartigimod in Myasthenia Gravis
por: Langley, Paul C.
Publicado: (2021)

ACHR-Positive Generalized Myasthenia Gravis: The Old is Gold and the New Is for us to Explore
por: Hiew, Fu Liong
Publicado: (2023)

Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis
por: Ahn, Jeeyun, et al.
Publicado: (2018)

Local use of dexamethasone in the treatment of ocular myasthenia gravis
por: Shi, Minghua, et al.
Publicado: (2020)

AZD-1222: Ocular myasthenia gravis: case report
Publicado: (2022)

Diagnostic yields and clinical features of ocular myasthenia gravis
por: Kim, Hyuna, et al.
Publicado: (2021)

Prognostic factors for conversion to generalization in ocular myasthenia gravis
por: Witthayaweerasak, Juthamat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rrg7bh73k5l5oj4jn6ru2r3kii